Published in Exp Neurol on December 11, 2009
Spinal cord trauma and the molecular point of no return. Mol Neurodegener (2012) 1.00
Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 0.81
The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. BMC Genomics (2010) 0.79
Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression. Front Cell Neurosci (2015) 0.78
Acute Traumatic Brain Injury Does Not Exacerbate Amyotrophic Lateral Sclerosis in the SOD1 (G93A) Rat Model(1,2,3). eNeuro (2015) 0.75
ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron (2006) 7.82
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci (2007) 7.77
Amyotrophic lateral sclerosis. N Engl J Med (2001) 7.37
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci (2001) 6.48
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol (2004) 6.26
Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci (2007) 6.08
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 5.89
Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci (2004) 5.70
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2006) 4.52
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A (2002) 4.37
Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell (2008) 3.97
Molecular profile of reactive astrocytes--implications for their role in neurologic disease. Neuroscience (1993) 3.51
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell (2008) 3.34
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain (2005) 2.94
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 2.87
Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia (1998) 2.82
GFAP and astrogliosis. Brain Pathol (1994) 2.79
Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci (2008) 2.67
Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci (2007) 2.48
A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev (2004) 2.14
GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99
Quantitative aspects of reactive gliosis: a review. Neurochem Res (1992) 1.74
GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther (2005) 1.72
Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell (2001) 1.71
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.65
Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med (1994) 1.58
Head injury and amyotrophic lateral sclerosis. Am J Epidemiol (2007) 1.50
Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci (2008) 1.38
Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration. Prog Brain Res (2009) 1.35
Astroglia in CNS injury. Glia (1991) 1.32
Reactions of the immune system in chronic degenerative neurological diseases. Can J Neurol Sci (1991) 1.29
Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta (2006) 1.26
Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler (2007) 1.13
Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells. Glia (2009) 1.12
Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci (2007) 0.99
Gene Therapy for ALS: progress and prospects. Biochim Biophys Acta (2006) 0.86
Crosstalk between astrocytes and motor neurons: what is the message? Exp Neurol (2008) 0.83
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Oxygen saturation and outcomes in preterm infants. N Engl J Med (2013) 4.96
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 4.51
Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med (2013) 2.89
Use of hybridization kinetics for differentiating specific from non-specific binding to oligonucleotide microarrays. Nucleic Acids Res (2002) 2.77
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet (2002) 2.29
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther (2008) 2.14
GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99
'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum (2002) 1.87
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol (2005) 1.86
GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther (2005) 1.72
Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation (2010) 1.64
Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons. J Neurochem (2011) 1.51
Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination. J Neurosci (2003) 1.44
Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One (2012) 1.40
Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci (2008) 1.38
Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One (2007) 1.38
Three-dimensional imaging of single isolated cell nuclei using optical projection tomography. Opt Express (2005) 1.38
Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice. Hippocampus (2005) 1.36
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. Eur J Pharmacol (2004) 1.36
Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol (2007) 1.36
Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol (2004) 1.35
Gene expression in human neural stem cells: effects of leukemia inhibitory factor. J Neurochem (2003) 1.34
Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res (2006) 1.33
Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I. J Cell Biol (2003) 1.30
Stable and efficient cassette exchange under non-selectable conditions by combined use of two site-specific recombinases. Nucleic Acids Res (2002) 1.30
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. Proc Natl Acad Sci U S A (2010) 1.29
Differentiating embryonic neural progenitor cells induce blood-brain barrier properties. J Neurochem (2007) 1.29
Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol (2011) 1.26
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25
Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov (2010) 1.24
Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci (2008) 1.22
A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2008) 1.21
Using human neural stem cells to model neurological disease. Nat Rev Genet (2004) 1.20
Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. Am J Respir Crit Care Med (2012) 1.20
GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant (2008) 1.19
Crossroads in GDNF therapy for Parkinson's disease. Mov Disord (2006) 1.19
Isotope ratios of H, C, and O in CO2 and H2O of the martian atmosphere. Science (2013) 1.15
Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. J Cell Biol (2010) 1.14
Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler (2007) 1.13
Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. Hum Mol Genet (2007) 1.13
Estimating efficacy and drug ED50's using von Frey thresholds: impact of weber's law and log transformation. J Pain (2012) 1.13
Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One (2009) 1.13
FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development (2003) 1.11
Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods (2007) 1.11
Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci U S A (2004) 1.10
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
Transmission of Armillifer armillatus ova at snake farm, The Gambia, West Africa. Emerg Infect Dis (2011) 1.08
Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci (2006) 1.07
Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Neurosurgery (2009) 1.06
Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther (2013) 1.06
Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant (2008) 1.05
Posttraumatic GABA(A)-mediated [Ca2+]i increase is essential for the induction of brain-derived neurotrophic factor-dependent survival of mature central neurons. J Neurosci (2008) 1.04
5-Bromo-2'-deoxyuridine is selectively toxic to neuronal precursors in vitro. Eur J Neurosci (2005) 1.03
Investigation into a role for the primitive streak in development of the murine allantois. Development (2003) 1.03
Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells (2004) 1.03
Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1. Stem Cells (2009) 1.02
Normal Neurogenesis but Abnormal Gene Expression in Human Fragile X Cortical Progenitor Cells. Stem Cells Dev (2008) 1.02
Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp Neurol (2006) 1.02
Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell (2012) 1.01
Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res (2002) 1.01
Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm Pharmacol Ther (2005) 1.01
The amazing astrocyte. Nature (2002) 1.00
Stem cells as a potential treatment of neurological disorders. Curr Opin Pharmacol (2004) 0.98
A high concentration of epidermal growth factor increases the growth and survival of neurogenic radial glial cells within human neurosphere cultures. Stem Cells (2007) 0.96
Low concentrations of extracellular FGF-2 are sufficient but not essential for neurogenesis from human neural progenitor cells. Mol Cell Neurosci (2006) 0.95
Rotenone-induced caspase 9/3-independent and -dependent cell death in undifferentiated and differentiated human neural stem cells. J Neurochem (2005) 0.95
Stem cell biologists sure play a mean pinball. Nat Biotechnol (2010) 0.94
Behavioral and autonomic dynamics during contextual fear conditioning in mice. Auton Neurosci (2004) 0.94
Regulation of prenatal human retinal neurosphere growth and cell fate potential by retinal pigment epithelium and Mash1. Stem Cells (2008) 0.93
Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. Exp Neurol (2010) 0.93
The single nuclear lamin of Caenorhabditis elegans forms in vitro stable intermediate filaments and paracrystals with a reduced axial periodicity. J Mol Biol (2003) 0.93
Mechanism of action of A-85380 in an animal model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.93
Stem cell transplantation for motor neuron disease: current approaches and future perspectives. Neurotherapeutics (2011) 0.92
BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons. Neurochem Res (2011) 0.91
Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci (2014) 0.91
EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS. Brain Res Bull (2005) 0.91
Stimulation of GABA-induced Ca2+ influx enhances maturation of human induced pluripotent stem cell-derived neurons. PLoS One (2013) 0.90
A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci (2008) 0.90
Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations. J Pharm Sci (2007) 0.90
Isolating, expanding, and infecting human and rodent fetal neural progenitor cells. Curr Protoc Stem Cell Biol (2008) 0.90
Comparison of extended field-of-view reconstructions in C-arm flat-detector CT using patient size, shape or attenuation information. Phys Med Biol (2010) 0.90
Premalignant and malignant cells in sputum from lung cancer patients. Cancer (2009) 0.90
A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. Dev Neurosci (2009) 0.89
Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89
Cardiac dynamics during daily torpor in the Djungarian hamster (Phodopus sungorus). Am J Physiol Regul Integr Comp Physiol (2007) 0.89
New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm (2012) 0.88